Blood test may predict cancer drug success
NCT ID NCT07555600
First seen Apr 30, 2026 · Last updated May 15, 2026 · Updated 2 times
Summary
This study looks at whether a blood test that counts and analyzes circulating tumor cells can predict how well certain cancer drugs (PARP inhibitors) work in people with advanced breast, prostate, pancreatic, or ovarian cancer. Researchers will collect blood samples from 300 adults before they start treatment and track their cancer progression over time. The goal is to see if the test can help doctors choose the right treatment for each patient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.